Anavex Life Sciences Corp (AVXL)

[tradeherpete]

From this morning's Form, on Rett Syndrome-

A high enrollment rate in the Open Label Extension (“OLE”) of over 91% and the high level of requests for the Compassionate Use Program (93%) provide solid numerical evidence for the reported positive Real World Evidence (RWE) from patients with Rett syndrome under Compassionate Use Authorization. Families whose children were previously on drug or placebo in the placebo-controlled trial commented favorably on the improvement of their child’s daily life due to ANAVEX®2-73 treatment in the Compassionate Use Program.

My comment;

The positive results for Blarcamesine were in the face of a World Pandemic, a testament to its strength and ability to overcome adversity.